Skip to content
cccskills
FreePublished on GitHub

esa-pa-interpret-avs

Determines unilateral vs bilateral aldosterone excess based on cortisol-corrected aldosterone ratios from adrenal venous sampling, with ratio >4:1 indicating unilateral excess, ratio 3:1 suggestive of bilateral hypersecretion, and interpretation dependent on cosyntropin stimulation protocol used during sampling. Use when analyzing AVS results to guide surgical vs medical treatment decisions; triggers include 'AVS lateralization ratio', 'cosyntropin-stimulated AVS', 'aldosterone-to-cortisol ratio >4:1', and 'ratio 3:1 suggestive of bilateral disease'.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md3.8 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Interpret Adrenal Venous Sampling Results for PA

STEP 1 — Gather Information

Collect aldosterone and cortisol concentrations from the right adrenal vein (RAV), left adrenal vein (LAV), and a peripheral vein (e.g., cubital or iliac). Document whether cosyntropin stimulation was administered (continuous infusion, bolus, or none) and note patient age, serum potassium, and adrenal CT findings (unilateral lesion, bilateral hyperplasia, or normal).

STEP 2 — Rule In / Rule Out

Determine if cosyntropin stimulation was used during AVS. If yes, proceed to calculate the high-side/low-side cortisol-corrected aldosterone ratio (higher aldosterone/cortisol divided by lower). If no, proceed to calculate adrenal vein aldosterone/cortisol ratios and compare each to peripheral vein ratio while assessing contralateral suppression (contralateral aldosterone/cortisol not higher than peripheral).

STEP 3 — Classify or Stratify

If cosyntropin used: a cortisol-corrected aldosterone ratio >4:1 indicates unilateral aldosterone excess; a ratio of 3:1 suggests bilateral hypersecretion; a ratio between 3:1 and 4:1 is indeterminate and requires correlation with clinical setting, CT, and possible repeat AVS. If cosyntropin not used: unilateral disease is suggested when the high-side/low-side ratio >2:1 (or adrenal vein aldosterone/cortisol ratio ≥2.5 times peripheral) with contralateral suppression; bilateral disease is suggested when ratios are similar or lack contralateral suppression.

STEP 4 — Decide

If unilateral aldosterone excess is confirmed, recommend laparoscopic adrenalectomy of the affected side (surgical cure). If bilateral hypersecretion or indeterminate result, recommend medical therapy with a mineralocorticoid receptor antagonist (e.g., spironolactone) and consider repeat AVS or ancillary tests if indeterminate.

Clinical Guardrails / Mimics / Pitfalls

Do not rely on AVS if catheterization unsuccessful (especially right adrenal vein); avoid interpreting results without cortisol correction; do not use AVS in patients with low aldosterone levels (<15 ng/dL) as ratios may be falsely elevated; do not overlook contralateral suppression; avoid AVS in patients with uncontrolled hypertension or severe hypokalemia without preparation; do not ignore clinical context (age <35 with spontaneous hypokalemia and unilateral CT lesion may proceed to surgery without AVS); do not mistake CT unilateral nodules for unilateral disease in bilateral hyperplasia.

Concrete Clinical Example

A 32‑year‑old woman with spontaneous hypokalemia, PAC 32 ng/dL, AVS performed with continuous cosyntropin infusion. Right adrenal vein: aldosterone 1800 ng/dL, cortisol 20 µg/dL (ratio 90). Left adrenal vein: aldosterone 400 ng/dL, cortisol 22 µg/dL (ratio 18.2). Peripheral: aldosterone 10 ng/dL, cortisol 10 µg/dL. High/low ratio = 90/18.2 ≈ 4.9 (>4:1), indicating unilateral aldosterone excess (right side). Laparoscopic right adrenalectomy is recommended.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2015-4061

TODO: consider adding scripts/calc.py for the esa-pa-interpret-avs calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill